Tested new blood vessel graft for a heart surgery
Part of Genetic & congenital, Heart & circulation clinical trials.
This trial studies whether a newer “tissue-engineered” blood vessel graft is safe and works well in children who need a specific heart surgery connection outside the heart. It may help by offering a new type of graft, but your team will screen for size and medical factors first.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child is scheduled for a specific heart surgery called an extracardiac total cavopulmonary connection
- You (or your legal guardian) can give permission, and your child can agree if they are able
- Surgery is planned (not urgent or emergency)
- The new graft size needed is between 12 mm and 24 mm in diameter
- Your child does not have a pacemaker
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This registry study checks whether a new venous blood tube used with a heart pump is safe and practical for people whose right heart is failing and who may need a heart transplant. If you qualify, your care team would monitor how the device works over time.
This trial tests a lab-grown blood vessel that is designed to be used as an extra bypass graft during heart surgery. It aims to offer a safe alternative for patients who need multiple bypasses, and the new vessel may help improve long-term blood flow.
This study tests a new surgical method to repair the pulmonary arteries (the vessels that carry blood to the lungs) in young children who were born with them not properly connected. The goal is to improve blood flow to the lungs and help your child's heart work better.
This trial tests a lab-made blood vessel (called an ATEV) used as a bypass graft during heart surgery. The ATEV is designed for people who don't have enough healthy leg vein for standard bypass grafts, and it may help restore blood flow to the heart more safely.
This study tests an early, first-use version of a new pulmonary valve device for children whose own valve is not working well. It may help improve blood flow from the heart to the lungs and aims to learn how safe and effective the valve is over time.
This trial tests whether transplanting tiny heart “micrografts” from the left heart chamber area can improve heart function after cardiac surgery. It is meant for people with weakened heart pumping and heart failure symptoms despite medicine.
Hear when a new Single-ventricle trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.